Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 11, 2001, Pages 3092-3097

  Rodriguez Cerrato, V ^a   McCoig, C C ^a   Michelow, I C ^a   Ghaffar, F ^a   Jafri, H S ^a   Hardy, R D ^a   Patel, C ^a   Olsen, K ^a   McCracken G H , Jr ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; MEROPENEM; MOXIFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BACTERIAL MENINGITIS; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; DRUG PENETRATION; ESCHERICHIA COLI; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; AZA COMPOUNDS; CEFTRIAXONE; CEPHALOSPORINS; ESCHERICHIA COLI; FLUOROQUINOLONES; MALE; MENINGITIS, ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; QUINOLINES; RABBITS; THIENAMYCINS;

EID: 0034769961     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.11.3092-3097.2001     Document Type: Article

References (21)

1. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin
2. Pharmacodynamic properties of BAY 12-8039 on gram-positive and gram-negative organisms as demonstrated by studies of time-kill kinetics and postantibiotic effect
3. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
4. Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives
5. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
6. Non-compartmental analysis
7. Enterobacteriaceae meningitis in adults: A review of 20 consecutive cases 1977-97
8. Cefotaxime and aminoglycoside treatment of meningitis caused by gram-negative enteric organisms
9. Pharmacodynamics of fluoroquinolones
10. Efficacy of gatifloxacin in experimental Escherichia coli meningitis
11. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits
12. Pharmacodynamics of levofloxacin: A new paradigma for early clinical trials
13. Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis
14. Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits
15. Moxifloxacin in the therapy of experimental pneumococcal meningitis
16. Microbioassay of antimicrobial agents
17. Inhibition of penicillin transport from the cerebrospinal fluid after intracisternal inoculation of bacteria
18. The pharmacodynamics of β-lactams
19. Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration
20. In vitro activity of BAY 12-8039, a new fluoroquinolone